Singapore Builds Patent Capacity Ahead Of New System 17/05/2012 by Maricel Estavillo for Intellectual Property Watch 2 Comments The tiny island state of Singapore has begun to ramp up its capacity for patent search and examination ahead of a bold move to adopt a new patent system, one of the proposed major amendments to its Patents Act. The Southeast Asian economic high-flyer is pressing for changes to its laws to position itself as an Asian hub for intellectual property.
WIPO, EPO Sign Patent Cooperation Agreement 03/05/2012 by Intellectual Property Watch Leave a Comment The heads of the World Intellectual Property Organization and the European Patent Office today signed a three-year agreement to mutually improve the procedural framework of the Patent Cooperation Treaty (PCT).
Medicines Patent Pool Director Ellen ‘t Hoen To Leave Next Month 16/04/2012 by William New, Intellectual Property Watch 2 Comments Executive Director Ellen ‘t Hoen is departing the Medicines Patent Pool, the cutting edge UN spin-off project that works to lower prices on and stimulate new development of HIV medicines and other products through negotiating voluntary licence agreements. According to a release, ‘t Hoen has fulfilled the mission of guiding the organisation from a startup onto “firm footing” and has informed the Board that she will leave on 1 May.
US Supreme Court Edges Toward Reviewing Extent Of GMO Patents 13/04/2012 by Steven Seidenberg for Intellectual Property Watch Leave a Comment It’s unclear if the US Supreme Court wants to address yet another controversial issue in patent law, but on 2 April, the court took a small step in that direction. That’s when the court formally asked the US Justice Department to opine on whether the high court should grant certiorari in Bowman v. Monsanto Co.
EPO Response: No Tricks On Patents On Seeds And Plants 05/04/2012 by Catherine Saez, Intellectual Property Watch 1 Comment In response to a report published on 3 April by civil society group No Patent on Seeds alleging that industry and patent examiners in the European Patent Office are finding legal loopholes to grant patents on seeds and plants, an EPO spokesperson told Intellectual Property Watch the patent office does not “apply tricks” to grant patents.
After Mayo, Is Patent Law More Restrictive In US Than Europe? 05/04/2012 by Steven Seidenberg for Intellectual Property Watch 1 Comment The United States is known for taking an unusually expansive approach towards patentable subject matter. Compared with Western Europe, for instance, the US has been far readier to grant patents on business methods, medical diagnostic processes, and human genes.
Group Says Industry, EPO Finding Loopholes To Patent Seeds, Plants 04/04/2012 by Catherine Saez, Intellectual Property Watch Leave a Comment A new report by civil society group No Patent on Seeds was issued yesterday alleging that industry and patent examiners in the European Patent Office are “using legal loopholes to grant patents on seeds, plants and even harvest and food products derived thereof.”
US Supreme Court Reverses Myriad Decision Allowing Gene Patents 27/03/2012 by Intellectual Property Watch 1 Comment The United States Supreme Court yesterday threw out a high-profile case that had allowed a private company’s patents on two human genes associated with cancer.
US Supreme Court Narrows Patentable Subject Matter 21/03/2012 by Intellectual Property Watch 3 Comments On 20 March, the US Supreme Court cut back on the types of inventions that can be patented in America. The court held in Mayo Collaborative Services v. Prometheus Labs., Inc. that one cannot patent an invention which merely applies known technology to natural phenomena.
Brazil HIV Drug Patent Ruling Allows Generics, Sends Pipeline Process Into Doubt 21/03/2012 by William New, Intellectual Property Watch 4 Comments Word is spreading of a recent decision by a Brazilian judge to annul a patent on a key AIDS drug, effectively allowing less expensive generic versions into the country, and calling into question other such patents.